Angie Godinez, Author at Bioscience Americas - Page 2 of 8

December 2016

Bioscience Americas Lauds Passage of the 21st Century Cures Act

Bioscience Americas CEO Eric Stoffers had nothing but praise for the U.S. House of Representatives’ and the U.S. Senate’s passage of the 21st Century Cures Act. “We’ve been strong advocates of this legislation which will streamline the approval process within the National Institutes of Health and the Food and Drug Administration (FDA)”, Mr. Stoffers said. The Act is expected to be signed into law soon by President Obama. Mr. Stoffers said that stem cells, because of their ability [...]

Stem Cells Can Successfully Treat Patients With Type 1 Diabetes

Millions of people around the world live with type one diabetes, a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent the disease, but according to Bioscience Americas CEO Eric Stoffers, there is a way to lessen dependency on costly pharmaceutical treatments while at the same time provide a degree of hope for a cure. The potential for a cure and the reality of lesser dependency on drugs comes through the use of [...]

November 2016

President-Elect Trump Wants to Speed Up FDA Approvals

As reported today in the New York Times, a single sentence in President-elect Donald Trump's health-care platform sends a strong hint to the drug and medical device industry that they may have an easier time getting their products on the market under his administration. “Reform the Food and Drug Administration, to put greater focus on the need of patients for new and innovative medical products,” his health plan states. On the face of it, the bullet point may seem almost bland, [...]

October 2016

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, and potentially, other cell types. For years, it has been clear that MSCs are a leading type of stem cell being investigated for therapeutic applications, because they have the potential to treat a wide range of acute and degenerative diseases. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that [...]

Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing

Bioscience Americas Senior Scientific Advisor Dr. Leslie Miller participated as a recognized expert in the field of stem cell biology at a major U.S. Food and Drug Administration (FDA) public hearing held recently at the National Institutes of Health in Bethesda, Maryland. The public hearing, attended in-person and on-line by more than 1,000 stem cell researchers and medical professionals, addressed the issue of FDA regulation of human cells, tissues, and cellular and tissue-based products and the FDA’s related draft Guidelines [...]

Bioscience Americas Sponsors Charitable Foundation

Bioscience Americas, LLC, a leading global developer of autologous stem cell treatment centers announced today the creation of a 501 (c) (3) qualified not-for-profit charitable entity to be called Solutions for a Healthier World Foundation, Inc. According to Bioscience Americas CEO Eric Stoffers, the Foundation’s mission will be to provide stem cell treatments to patients suffering from autoimmune diseases who are unable to afford the cost of Bioscience Americas innovative therapies. “As we advance our efforts to develop stem cell wellness [...]

September 2016

Bioscience Americas Announces New Cellular Immunotherapy Treatment

Bioscience Americas, LLC, the leading international developer of autologous stem cell treatment centers, is pleased to announce that it has added cellular immunotherapy for the treatment of cancer to its list of therapies available to patients at its Hospital treatment center in Rionegro, Antioquia, Colombia. Cellular immunotherapy is an innovative new technology developed in the laboratories of Bioscience Americas by its science partner, the Global Institute of Stem Cell Therapy and Research (GIOSTAR). The treatment represents a break-through [...]

Drug Prices Keep Rising

From the campaign trail to the halls of Congress, drug makers have spent much of the last year enduring withering criticism over the rising cost of drugs. It doesn’t seem to be working. In April alone, Johnson & Johnson raised its prices on several top-selling products, including the leukemia drug Imbruvica, the diabetes treatment Invokana, and Xarelto, an anti-clotting drug, according to a research note published last week by an analyst for Leerink, an investment bank. Other major companies that have [...]

August 2016

Alzheimer’s and Stem Cell

Some Alzheimer’s disease researchers are using stem cells in a novel way—as a model of the disease outside the human body, enabling more efficient testing of experimental drugs in the lab rather than in clinical trials with people. Finding a drug to slow the onset of Alzheimer’s, the major cause of dementia in older people, has been frustratingly elusive. That is partly because animal testing, where most research begins, doesn’t often produce results that predict very well what will happen [...]

The Laura Dominguez Story

If there was ever a woman on a mission, it’s Laura Dominguez. Doctors once told her she’d never walk again. And while she’s not ready to run a marathon, she’s already proving them wrong, with the best yet to come. An oil spill on a San Antonio freeway is blamed for the car crash that sent Laura and her brother directly into a retaining wall one summer afternoon in 2001. Laura was just 16 years old at [...]